🇺🇸 FDA
Patent

US 7985769

Compounds and methods for the treatment or prevention of Flavivirus infections

granted A61KA61K31/20A61K31/341

Quick answer

US patent 7985769 (Compounds and methods for the treatment or prevention of Flavivirus infections) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
61
CPC classes
A61K, A61K31/20, A61K31/341, A61K31/343, A61K31/381